Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria.
Watson OJ, Alhaffar M, Mehchy Z, Whittaker C, Akil Z, Brazeau NF, Cuomo-Dannenburg G, Hamlet A, Thompson HA, Baguelin M, FitzJohn RG, Knock E, Lees JA, Whittles LK, Mellan T, Winskill P; Imperial College COVID-19 Response Team; Howard N, Clapham H, Checchi F, Ferguson N, Ghani A, Beals E, Walker P. Watson OJ, et al. Nat Commun. 2021 Apr 22;12(1):2394. doi: 10.1038/s41467-021-22474-9. Nat Commun. 2021. PMID: 33888698 Free PMC article.
Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia.
Meier-Scherling CPG, Watson OJ, Asua V, Ghinai I, Katairo T, Garg S, Conrad M, Rosenthal PJ, Okell LC, Bailey JA. Meier-Scherling CPG, et al. Among authors: watson oj. medRxiv [Preprint]. 2024 Feb 4:2024.02.03.24302209. doi: 10.1101/2024.02.03.24302209. medRxiv. 2024. PMID: 38352505 Free PMC article. Preprint.
High frequency of artemisinin partial resistance mutations in the Great Lakes region revealed through rapid pooled deep sequencing.
Wernsman Young N, Gashema P, Giesbrecht D, Munyaneza T, Maisha F, Mwebembezi F, Budodo R, Leonetti A, Crudale R, Iradukunda V, Jean Bosco N, Kirby RI, Boyce RM, Mandara CI, Kanyankole GK, Ntaro M, Okell LC, Watson OJ, Mulogo E, Ishengoma DS, Hangi S, Karema C, Mazarati JB, Juliano JJ, Bailey JA. Wernsman Young N, et al. Among authors: watson oj. J Infect Dis. 2024 Oct 5:jiae475. doi: 10.1093/infdis/jiae475. Online ahead of print. J Infect Dis. 2024. PMID: 39367758
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
Chemwor GC, Andagalu BM, Onyango IA, Opot BH, Okoth RO, Yedah RA, Juma JA, Mwakio EW, Wakoli DM, Amwoma JG, Cheruiyot AC, Juma DW, Ogutu BR, Egbo TE, Garges EC, Roth AL, Kamau E, Watson OJ, Akala HM. Chemwor GC, et al. Among authors: watson oj. Int J Infect Dis. 2023 Jul;132:17-25. doi: 10.1016/j.ijid.2023.04.008. Epub 2023 Apr 14. Int J Infect Dis. 2023. PMID: 37061211 Free article. Clinical Trial.
Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa.
Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, Bennett A, Verity R, Gething P, Roper C, Alifrangis M. Okell LC, et al. Among authors: watson oj. BMJ Glob Health. 2018 Oct 19;3(5):e000999. doi: 10.1136/bmjgh-2018-000999. eCollection 2018. BMJ Glob Health. 2018. PMID: 30397515 Free PMC article.
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
Slater HC, Foy BD, Kobylinski K, Chaccour C, Watson OJ, Hellewell J, Aljayyoussi G, Bousema T, Burrows J, D'Alessandro U, Alout H, Ter Kuile FO, Walker PGT, Ghani AC, Smit MR. Slater HC, et al. Among authors: watson oj. Lancet Infect Dis. 2020 Apr;20(4):498-508. doi: 10.1016/S1473-3099(19)30633-4. Epub 2020 Jan 13. Lancet Infect Dis. 2020. PMID: 31948767 Free article.
80 results